Startseite Lipoprotein(a) level and its association with tumor stage in male patients with primary lung cancer
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Lipoprotein(a) level and its association with tumor stage in male patients with primary lung cancer

  • Hai-hua Yang , Xiao-feng Chen , Wei Hu , Dong-qing Lv , Wei-jun Ding , Li-jiang Tang , Jian-jun Jiang und Min-hua Ye
Veröffentlicht/Copyright: 18. Februar 2009
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Recently, attention has been focused on the effect of lipoprotein(a) [Lp(a)] on tumors because of its possible role in development of tumor angiogenesis. The aim of this study was to investigate Lp(a) serum levels in patients with lung cancer and its association with the stages of disease.

Methods: Fasting venous blood samples were collected from 418 untreated male patients with stages I–IV lung carcinoma and were analyzed for Lp(a). The results were compared with the data from 65 healthy male controls.

Results: Lp(a) levels were elevated (median 157 mg/L, range 16–1497 mg/L) in patients with lung carcinoma compared to control subjects (median 110 mg/L, range 35–706 mg/L) (p=0.004). Subgroup analysis showed that patients with stages II–IV disease had significantly higher Lp(a) concentrations than did healthy controls (p<0.05). There was an independently positive correlation between tumor stage and Lp(a) levels among patients with stages I–III (r=0.162, p=0.006). However, there was a decrease in Lp(a) in stage IV compared to stage III patients (p=0.03).

Conclusions: There is a significant association between Lp(a) and the presence and stage of lung cancer. Additional investigations with a larger number of lung cancer patients are needed to confirm these findings.

Clin Chem Lab Med 2009;47:452–7.


Corresponding author: Xiao-feng Chen, Department of Cardiovascular Diseases, Taizhou Hospital, Wenzhou Medical College, Taizhou, 317000, Zhejiang, China Phone: +86-138-19639007, Fax: +86-576-85199876,

Received: 2008-10-3
Accepted: 2009-1-5
Published Online: 2009-02-18
Published in Print: 2009-04-01

©2009 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Minireview
  2. Risk loci for type 2 diabetes – Quo vadis?
  3. Genetics and Molecular Diagnostics
  4. A common variant in the FTO gene is associated with body mass index in males and postmenopausal females but not in premenopausal females. Czech post-MONICA and 3PMFs studies
  5. Genotype distribution of estrogen receptor α polymorphisms in pregnant women from healthy and preeclampsia populations and its relation to blood pressure levels
  6. Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis?
  7. The selection and application of ssDNA aptamers against MPT64 protein in Mycobacterium tuberculosis
  8. Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma
  9. Expression of lineage markers using real-time quantitative polymerase chain reaction (RT-qPCR) in normal and in leukemia bone marrow
  10. Translation termination and protein folding pathway genes are not correlated in gastric cancer
  11. General Clincial Chemistry and Laboratory Medicine
  12. Novel serum paraoxonase activity assays are associated with coronary artery disease
  13. Elevated erythrocyte carbonic anhydrase activity is a novel clinical marker in hyperventilation syndrome
  14. Elevation of the glycoxidation product Nε-(carboxymethyl)lysine in patients presenting with acute myocardial infarction
  15. Lipoprotein(a) level and its association with tumor stage in male patients with primary lung cancer
  16. A high-performance liquid chromatography method for the determination of carbamazepine and carbamazepine-10,11-epoxide and its comparison with chemiluminescent immunoassay
  17. Reference Values and Biological Variations
  18. Minimizing the effects of multicollinearity in the polynomial regression of age relationships and sex differences in serum levels of pregnenolone sulfate in healthy subjects
  19. Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations
  20. Validation and Outcome Studies
  21. Analytical precision of the Urolizer® for the determination of the BONN-Risk-Index (BRI) for calcium oxalate urolithiasis and evaluation of the influence of 24-h urine storage at moderate temperatures on BRI
  22. Determination of nitrotyrosine concentrations in plasma samples of diabetes mellitus patients by four different immunoassays leads to contradictive results and disqualifies the majority of the tests
  23. Estimation of trueness of measurement results obtained in external quality assessment
  24. Letters to the Editor
  25. A new PCR-RFLP assay for –1123 G>C polymorphism in the PTPN22 gene: allele and genotype frequencies in a western Mexican population
  26. Proposed classification of various limit values (guide values) used in assisting the interpretation of quantitative laboratory test results
  27. Case report: Over-substitution of thyroxine due to interference in serum thyroid-stimulating hormone measurement
  28. Rv2629 191A/C nucleotide change is not associated with rifampicin resistance in Mycobacterium tuberculosis
Heruntergeladen am 5.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.094/html
Button zum nach oben scrollen